检测新鲜及“陈旧”血液和骨髓中的JAK2 V617F突变。 - Suppr | 超能文献

Detecting the JAK2 V617F mutation in fresh and 'historic' blood and bone marrow.

作者信息

Gattenlohner S, Peter C, Bonengel M, Einsele H, Bargou R, Müller-Hermelink H-K, Marx A

出版信息

Leukemia. 2007 Jul;21(7):1599-602. doi: 10.1038/sj.leu.2404701. Epub 2007 Apr 26.

DOI:10.1038/sj.leu.2404701

Abstract

摘要

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

相似文献

1

Detecting the JAK2 V617F mutation in fresh and 'historic' blood and bone marrow.检测新鲜及“陈旧”血液和骨髓中的JAK2 V617F突变。

Leukemia. 2007 Jul;21(7):1599-602. doi: 10.1038/sj.leu.2404701. Epub 2007 Apr 26.

2

Evaluation of JAK2 in B and T cell neoplasms: identification of JAK2(V617F) mutation of undetermined significance (JMUS) in the bone marrow of three individuals.B细胞和T细胞肿瘤中JAK2的评估：三名个体骨髓中JAK2（V617F）意义未明突变（JMUS）的鉴定。

Acta Haematol. 2007;118(4):209-14. doi: 10.1159/000111532. Epub 2007 Nov 21.

3

Bone marrow mesenchymal stromal cells of patients with myeloproliferative disorders do not carry the JAK2-V617F mutation.骨髓增殖性疾病患者的骨髓间充质基质细胞不携带JAK2-V617F突变。

Exp Hematol. 2009 Mar;37(3):416-20. doi: 10.1016/j.exphem.2008.11.008. Epub 2009 Jan 9.

4

Frequent detection of the JAK2 V617F mutation in bone marrow core biopsy specimens from chronic myeloproliferative disorders using the TaqMan polymerase chain reaction single nucleotide polymorphism genotyping assay: a retrospective study with pathologic correlations.运用TaqMan聚合酶链反应单核苷酸多态性基因分型检测法在慢性骨髓增殖性疾病骨髓活检标本中频繁检测JAK2 V617F突变：一项具有病理相关性的回顾性研究

Hum Pathol. 2006 Nov;37(11):1458-64. doi: 10.1016/j.humpath.2006.05.006. Epub 2006 Jul 26.

5

Identification of oncostatin M as a JAK2 V617F-dependent amplifier of cytokine production and bone marrow remodeling in myeloproliferative neoplasms.鉴定出孤啡肽作为 JAK2 V617F 依赖性细胞因子产生和骨髓重构的扩增剂在骨髓增殖性肿瘤中的作用。

FASEB J. 2012 Feb;26(2):894-906. doi: 10.1096/fj.11-193078. Epub 2011 Nov 3.

6

Constitutive JunB expression, associated with the JAK2 V617F mutation, stimulates proliferation of the erythroid lineage.与JAK2 V617F突变相关的组成型JunB表达刺激红系谱系的增殖。

Leukemia. 2009 Jan;23(1):144-52. doi: 10.1038/leu.2008.275. Epub 2008 Oct 9.

7

Detection of the JAK2 V617F missense mutation by high resolution melting analysis and its validation.通过高分辨率熔解分析检测JAK2 V617F错义突变及其验证

Clin Chim Acta. 2009 Oct;408(1-2):39-44. doi: 10.1016/j.cca.2009.07.002. Epub 2009 Jul 10.

8

Characterization of murine JAK2V617F-positive myeloproliferative disease.小鼠JAK2V617F阳性骨髓增殖性疾病的特征分析

Cancer Res. 2006 Dec 1;66(23):11156-65. doi: 10.1158/0008-5472.CAN-06-2210.

9

JAK2V617F activating mutation is associated with the myeloproliferative type of chronic myelomonocytic leukaemia.JAK2V617F激活突变与慢性粒单核细胞白血病的骨髓增殖型相关。

J Clin Pathol. 2009 Sep;62(9):798-801. doi: 10.1136/jcp.2009.065904.

10

JAK2 (V617F) mutation is not associated with thrombosis in Behcet syndrome.JAK2（V617F）突变与白塞综合征的血栓形成无关。

Clin Appl Thromb Hemost. 2012 Jul;18(4):421-6. doi: 10.1177/1076029611427440. Epub 2011 Dec 26.

引用本文的文献

1

Targeted sequencing of candidate gene regions for myelofibrosis in dogs.犬骨髓纤维化候选基因区域的靶向测序。

J Vet Intern Med. 2022 Jul;36(4):1237-1247. doi: 10.1111/jvim.16476. Epub 2022 Jul 11.

2

JAK2 p.V617F detection and allele burden measurement in peripheral blood and bone marrow aspirates in patients with myeloproliferative neoplasms.JAK2 p.V617F 检测及等位基因负荷在骨髓和外周血中的检测在骨髓增殖性肿瘤患者中的应用。

Blood. 2013 Nov 28;122(23):3784-6. doi: 10.1182/blood-2013-07-515676. Epub 2013 Sep 25.

3

Recent advances in the diagnosis and classification of myeloid neoplasms--comments on the 2008 WHO classification.髓系肿瘤诊断和分类的最新进展——对 2008 年 WHO 分类的评论。

Int J Lab Hematol. 2010 Oct;32(5):461-76. doi: 10.1111/j.1751-553X.2010.01246.x. Epub 2010 Jul 7.